Berenberg Bank Raises Diploma (LON:DPLM) Price Target to GBX 6,350

Key Points

Error: Response status code does not indicate success: 503 (Service Unavailable).

Diploma (LON:DPLM - Get Free Report) had its price target upped by stock analysts at Berenberg Bank from GBX 5,750 to GBX 6,350 in a note issued to investors on Wednesday, Marketbeat Ratings reports. The firm currently has a "buy" rating on the stock. Berenberg Bank's price objective would indicate a potential upside of 16.49% from the stock's current price.

Several other analysts have also recently weighed in on DPLM. Shore Capital reaffirmed a "hold" rating and set a GBX 5,100 price objective on shares of Diploma in a research note on Thursday, July 17th. JPMorgan Chase & Co. reaffirmed a "neutral" rating and set a GBX 4,440 price objective on shares of Diploma in a research note on Wednesday, August 6th. Finally, Jefferies Financial Group increased their price target on shares of Diploma from GBX 4,500 to GBX 5,200 and gave the company a "hold" rating in a research note on Thursday, September 11th. Two research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of GBX 5,238.

Diploma Price Performance

Diploma stock traded down GBX 48.91 during trading hours on Wednesday, hitting GBX 5,451.10. 230,669 shares of the stock were exchanged, compared to its average volume of 467,316. The company has a debt-to-equity ratio of 62.17, a quick ratio of 0.80 and a current ratio of 2.17. The stock has a market capitalization of £7.31 billion, a P/E ratio of 4,385.43, a P/E/G ratio of 2.82 and a beta of 0.75. Diploma has a 12 month low of GBX 3,532 and a 12 month high of GBX 5,625. The business's 50-day moving average is GBX 5,299.66 and its two-hundred day moving average is GBX 4,632.25.

Diploma Company Profile

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.